首页 > 最新文献

Current Genomics最新文献

英文 中文
Genomic and Metagenomic Insights into the Distribution of Nicotine-Degrading Enzymes in Human Microbiota 人类微生物群中尼古丁降解酶分布的基因组学和元基因组学启示
IF 2.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-03-21 DOI: 10.2174/0113892029302230240319042208
Ying Guan, Zhouhai Zhu, Qiyuan Peng, Meng Li, Xuan Li, Jia-Wei Yang, Yan-Hong Lu, Meng Wang, Bin-Bin Xie
Introduction: Nicotine degradation is a new strategy to block nicotine-induced pathology. The potential of human microbiota to degrade nicotine has not been explored. Aims: This study aimed to uncover the genomic potentials of human microbiota to degrade nicotine. Method: To address this issue, we performed a systematic annotation of Nicotine-Degrading Enzymes (NDEs) from genomes and metagenomes of human microbiota. A total of 26,295 genomes and 1,596 metagenomes for human microbiota were downloaded from public databases and five types of NDEs were annotated with a custom pipeline. We found 959 NdhB, 785 NdhL, 987 NicX, three NicA1, and three NicA2 homologs. Results: Genomic classification revealed that six phylum-level taxa, including Proteobacteria, Firmicutes, Firmicutes_A, Bacteroidota, Actinobacteriota, and Chloroflexota, can produce NDEs, with Proteobacteria encoding all five types of NDEs studied. Analysis of NicX prevalence revealed differences among body sites. NicX homologs were found in gut and oral samples with a high prevalence but not found in lung samples. NicX was found in samples from both smokers and non-smokers, though the prevalence might be different.
介绍:尼古丁降解是阻止尼古丁诱发病理学的一种新策略。人类微生物群降解尼古丁的潜力尚未得到探索。目的:本研究旨在揭示人类微生物群降解尼古丁的基因组潜力。方法:为了解决这个问题,我们对人类微生物群基因组和元基因组中的尼古丁降解酶(NDEs)进行了系统注释。我们从公共数据库中下载了26,295个人类微生物群的基因组和1,596个元基因组,并使用定制管道注释了五种类型的尼古丁降解酶。我们发现了 959 个 NdhB、785 个 NdhL、987 个 NicX、3 个 NicA1 和 3 个 NicA2 同源物。结果基因组分类显示,六个门级类群,包括变形菌门、固形菌门、固形菌_A 门、类杆菌门、放线菌门和绿藻门,都能产生 NDEs,其中变形菌门编码了所研究的所有五种 NDEs。对 NicX 流行情况的分析表明,不同的身体部位存在差异。在肠道和口腔样本中发现的 NicX 同源物的流行率很高,但在肺部样本中却没有发现。在吸烟者和非吸烟者的样本中都发现了 NicX,但流行率可能有所不同。
{"title":"Genomic and Metagenomic Insights into the Distribution of Nicotine-Degrading Enzymes in Human Microbiota","authors":"Ying Guan, Zhouhai Zhu, Qiyuan Peng, Meng Li, Xuan Li, Jia-Wei Yang, Yan-Hong Lu, Meng Wang, Bin-Bin Xie","doi":"10.2174/0113892029302230240319042208","DOIUrl":"https://doi.org/10.2174/0113892029302230240319042208","url":null,"abstract":"Introduction: Nicotine degradation is a new strategy to block nicotine-induced pathology. The potential of human microbiota to degrade nicotine has not been explored. Aims: This study aimed to uncover the genomic potentials of human microbiota to degrade nicotine. Method: To address this issue, we performed a systematic annotation of Nicotine-Degrading Enzymes (NDEs) from genomes and metagenomes of human microbiota. A total of 26,295 genomes and 1,596 metagenomes for human microbiota were downloaded from public databases and five types of NDEs were annotated with a custom pipeline. We found 959 NdhB, 785 NdhL, 987 NicX, three NicA1, and three NicA2 homologs. Results: Genomic classification revealed that six phylum-level taxa, including Proteobacteria, Firmicutes, Firmicutes_A, Bacteroidota, Actinobacteriota, and Chloroflexota, can produce NDEs, with Proteobacteria encoding all five types of NDEs studied. Analysis of NicX prevalence revealed differences among body sites. NicX homologs were found in gut and oral samples with a high prevalence but not found in lung samples. NicX was found in samples from both smokers and non-smokers, though the prevalence might be different.","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"305 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140202090","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of Deleterious Single Amino Acid Polymorphisms with a Consensus Holdout Sampler 用共识保持取样器预测有害的单氨基酸多态性
IF 2.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-03-18 DOI: 10.2174/0113892029236347240308054538
Óscar Álvarez-Machancoses, Eshel Faraggi, Enrique deAndrés-Galiana, Juan Fernández-Martínez, Andrzej Kloczkowski
Background: Single Amino Acid Polymorphisms (SAPs) or nonsynonymous Single Nucleotide Variants (nsSNVs) are the most common genetic variations. They result from missense mutations where a single base pair substitution changes the genetic code in such a way that the triplet of bases (codon) at a given position is coding a different amino acid. Since genetic mutations sometimes cause genetic diseases, it is important to comprehend and foresee which variations are harmful and which ones are neutral (not causing changes in the phenotype). This can be posed as a classification problem. Methods: Computational methods using machine intelligence are gradually replacing repetitive and exceedingly overpriced mutagenic tests. By and large, uneven quality, deficiencies, and irregularities of nsSNVs datasets debase the convenience of artificial intelligence-based methods. Subsequently, strong and more exact approaches are needed to address these problems. In the present work paper, we show a consensus classifier built on the holdout sampler, which appears strong and precise and outflanks all other popular methods. objective: Roughly a half of known disease-related mutations are due to non-synonymous variants [8-9], expressed as amino-acid mutations. Therefore, it is important to unravel the links between nonsynonymous Single Nucleotide Variants and associated diseases to discriminate between pathogenic and neutral substitutions. It has been found that these substitutions could be directly related to pathological effects such as Parkinson’s or Alzheimer’s diseases, or to the involvement in complex diseases, such as cancer development. Results: We produced 100 holdouts to test the structures and diverse classification variables of diverse classifiers during the training phase. The finest performing holdouts were chosen to develop a consensus classifier and tested using a k-fold (1 ≤ k ≤5) cross-validation method. We also examined which protein properties have the biggest impact on the precise prediction of the effects of nsSNVs. Conclusion: Our Consensus Holdout Sampler outflanks other popular algorithms, and gives excellent results, highly accurate with low standard deviation. The advantage of our method emerges from using a tree of holdouts, where diverse LM/AI-based programs are sampled in diverse ways.
背景:单氨基酸多态性(SAP)或非同义单核苷酸变异(nsSNV)是最常见的基因变异。它们是由错义突变引起的,在错义突变中,单碱基对置换改变了遗传密码,使特定位置的三联碱基(密码子)编码不同的氨基酸。由于基因突变有时会导致遗传疾病,因此理解和预见哪些变异是有害的,哪些变异是中性的(不会导致表型变化)就显得尤为重要。这可以看作是一个分类问题。方法:使用机器智能的计算方法正逐渐取代重复性的、价格过高的诱变试验。总的来说,nsSNVs 数据集的质量参差不齐、缺陷和不规则性削弱了基于人工智能的方法的便利性。因此,需要更强大、更精确的方法来解决这些问题。在本论文中,我们展示了一种建立在holdout采样器基础上的共识分类器,它显得强大而精确,超越了所有其他流行方法:已知的与疾病相关的突变中大约有一半是由非同义变异引起的[8-9],表现为氨基酸突变。因此,揭示非同义单核苷酸变异与相关疾病之间的联系,以区分致病性和中性变异非常重要。研究发现,这些变异可能与帕金森病或阿尔茨海默病等病理效应直接相关,也可能与癌症发展等复杂疾病有关。结果在训练阶段,我们制作了 100 个暂存模型来测试不同分类器的结构和各种分类变量。我们选取了表现最出色的候选者来开发共识分类器,并使用 k 倍(1 ≤ k ≤5)交叉验证法进行测试。我们还研究了哪些蛋白质特性对精确预测 nsSNV 的影响影响最大。结论我们的 "共识保持采样器 "超越了其他流行的算法,取得了出色的结果,准确度高,标准偏差小。我们的方法的优势来自于使用一棵保留树,在这棵树上,基于 LM/AI 的不同程序以不同的方式进行采样。
{"title":"Prediction of Deleterious Single Amino Acid Polymorphisms with a Consensus Holdout Sampler","authors":"Óscar Álvarez-Machancoses, Eshel Faraggi, Enrique deAndrés-Galiana, Juan Fernández-Martínez, Andrzej Kloczkowski","doi":"10.2174/0113892029236347240308054538","DOIUrl":"https://doi.org/10.2174/0113892029236347240308054538","url":null,"abstract":"Background: Single Amino Acid Polymorphisms (SAPs) or nonsynonymous Single Nucleotide Variants (nsSNVs) are the most common genetic variations. They result from missense mutations where a single base pair substitution changes the genetic code in such a way that the triplet of bases (codon) at a given position is coding a different amino acid. Since genetic mutations sometimes cause genetic diseases, it is important to comprehend and foresee which variations are harmful and which ones are neutral (not causing changes in the phenotype). This can be posed as a classification problem. Methods: Computational methods using machine intelligence are gradually replacing repetitive and exceedingly overpriced mutagenic tests. By and large, uneven quality, deficiencies, and irregularities of nsSNVs datasets debase the convenience of artificial intelligence-based methods. Subsequently, strong and more exact approaches are needed to address these problems. In the present work paper, we show a consensus classifier built on the holdout sampler, which appears strong and precise and outflanks all other popular methods. objective: Roughly a half of known disease-related mutations are due to non-synonymous variants [8-9], expressed as amino-acid mutations. Therefore, it is important to unravel the links between nonsynonymous Single Nucleotide Variants and associated diseases to discriminate between pathogenic and neutral substitutions. It has been found that these substitutions could be directly related to pathological effects such as Parkinson’s or Alzheimer’s diseases, or to the involvement in complex diseases, such as cancer development. Results: We produced 100 holdouts to test the structures and diverse classification variables of diverse classifiers during the training phase. The finest performing holdouts were chosen to develop a consensus classifier and tested using a k-fold (1 ≤ k ≤5) cross-validation method. We also examined which protein properties have the biggest impact on the precise prediction of the effects of nsSNVs. Conclusion: Our Consensus Holdout Sampler outflanks other popular algorithms, and gives excellent results, highly accurate with low standard deviation. The advantage of our method emerges from using a tree of holdouts, where diverse LM/AI-based programs are sampled in diverse ways.","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"27 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140165510","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Testing the Significance of Ranked Gene Sets in Genome-Wide Transcriptome Profiling Data Using Weighted Rank Correlation Statistics 利用加权等级相关统计检验全基因组转录组图谱数据中等级基因集的显著性
IF 2.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-03-15 DOI: 10.2174/0113892029280470240306044159
Min Yao, Hao He, Binyu Wang, Xinmiao Huang, Sunli Zheng, Jianwu Wang, Xuejun Gao, Tinghua Huang
Objective: Ignoring the rank information during the enrichment analysis will lead to improper statistical inference. We address this issue by developing of new method to test the significance of ranked gene sets in genome-wide transcriptome profiling data. Methods: A method was proposed by first creating ranked gene sets and gene lists and then applying weighted Kendall's tau rank correlation statistics to the test. After introducing top-down weights to the genes in the gene set, a new software called "Flaver" was developed. Results: Theoretical properties of the proposed method were established, and its differences over the GSEA approach were demonstrated when analyzing the transcriptome profiling data across 55 human tissues and 176 human cell-lines. The results indicated that the TFs identified by our method have higher tendency to be differentially expressed across the tissues analyzed than its competitors. It significantly outperforms the well-known gene set enrichment analyzing tools, GOStats (9%) and GSEA (17%), in analyzing well-documented human RNA transcriptome datasets. Conclusions: The method is outstanding in detecting gene sets of which the gene ranks were correlated with the expression levels of the genes in the transcriptome data.
目的在富集分析过程中忽略等级信息将导致不恰当的统计推断。为了解决这个问题,我们开发了一种新方法来测试全基因组转录组图谱数据中等级基因集的重要性。方法:首先创建排序基因组和基因列表,然后应用加权 Kendall's tau 秩相关统计进行检验。在对基因集中的基因引入自上而下的权重后,开发了一种名为 "Flaver "的新软件。结果在分析 55 种人体组织和 176 种人体细胞系的转录组图谱数据时,建立了所提方法的理论特性,并证明了它与 GSEA 方法的不同之处。结果表明,与同类方法相比,我们的方法识别出的 TFs 在所分析的组织中具有更高的差异表达倾向。在分析有据可查的人类 RNA 转录组数据集时,它明显优于著名的基因组富集分析工具 GOStats(9%)和 GSEA(17%)。结论该方法在检测基因等级与转录组数据中基因表达水平相关的基因组方面表现突出。
{"title":"Testing the Significance of Ranked Gene Sets in Genome-Wide Transcriptome Profiling Data Using Weighted Rank Correlation Statistics","authors":"Min Yao, Hao He, Binyu Wang, Xinmiao Huang, Sunli Zheng, Jianwu Wang, Xuejun Gao, Tinghua Huang","doi":"10.2174/0113892029280470240306044159","DOIUrl":"https://doi.org/10.2174/0113892029280470240306044159","url":null,"abstract":"Objective: Ignoring the rank information during the enrichment analysis will lead to improper statistical inference. We address this issue by developing of new method to test the significance of ranked gene sets in genome-wide transcriptome profiling data. Methods: A method was proposed by first creating ranked gene sets and gene lists and then applying weighted Kendall's tau rank correlation statistics to the test. After introducing top-down weights to the genes in the gene set, a new software called \"Flaver\" was developed. Results: Theoretical properties of the proposed method were established, and its differences over the GSEA approach were demonstrated when analyzing the transcriptome profiling data across 55 human tissues and 176 human cell-lines. The results indicated that the TFs identified by our method have higher tendency to be differentially expressed across the tissues analyzed than its competitors. It significantly outperforms the well-known gene set enrichment analyzing tools, GOStats (9%) and GSEA (17%), in analyzing well-documented human RNA transcriptome datasets. Conclusions: The method is outstanding in detecting gene sets of which the gene ranks were correlated with the expression levels of the genes in the transcriptome data.","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"2012 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140147457","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of Calebin-A on Critical Genes Related to NAFLD: A Protein-Protein Interaction Network and Molecular Docking Study Calebin-A 对非酒精性脂肪肝相关关键基因的影响:蛋白质-蛋白质相互作用网络和分子对接研究
IF 2.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-27 DOI: 10.2174/0113892029280454240214072212
Ali Mahmoudi, Mohammad Mahdi Hajihasani, Muhammed Majeed, Tannaz Jamialahmadi, Amirhossein Sahebkar
Background:: Calebin-A is a minor phytoconstituent of turmeric known for its activity against inflammation, oxidative stress, cancerous, and metabolic disorders like Non-alcoholic fatty liver disease(NAFLD). Based on bioinformatic tools, the present study explored the intersection of possible targets that interacted with Calebin-A and the essential genes involved in NAFLD. Subsequently, the details of the interaction of critical proteins with Calebin-A were investigated using the molecular docking technique. Methods:: We first probed the intersection of genes/ proteins between NAFLD and Calebin-A through online databases. Besides, we performed an enrichment analysis using the ClueGO plugin to investigate signaling pathways and gene ontology. Next, we evaluate the possible interaction of Calebin-A with significant hub proteins involved in NAFLD through a molecular docking study. Results:: We identified 87 intersection genes Calebin-A targets associated with NAFLD. PPI network analysis introduced 10 hub genes (TP53, TNF, STAT3, HSP90AA1, PTGS2, HDAC6, ABCB1, CCT2, NR1I2, and GUSB). In KEGG enrichment, most were associated with Sphingolipid, vascular endothelial growth factor A (VEGFA), C-type lectin receptor, and mitogen-activated protein kinase (MAPK) signaling pathways. The biological processes described in 87 intersection genes are mostly concerned with regulating the apoptotic process, cytokine production, and intracellular signal transduction. Molecular docking results also directed that Calebin-A had a high affinity to bind hub proteins linked to NAFLD. Conclusion:: Here, we showed that Calebin-A, through its effect on several critical genes/ proteins and pathways, might repress the progression of NAFLD.
背景姜黄素-A是姜黄的一种次要植物成分,具有抗炎、抗氧化、抗癌和抗非酒精性脂肪肝等代谢性疾病的活性。本研究基于生物信息学工具,探索了与 Calebin-A 相互作用的可能靶点和非酒精性脂肪肝相关重要基因的交叉点。随后,利用分子对接技术研究了关键蛋白与 Calebin-A 相互作用的细节。研究方法首先,我们通过在线数据库探究了非酒精性脂肪肝和Calebin-A之间的基因/蛋白质交叉。此外,我们还使用 ClueGO 插件对信号通路和基因本体进行了富集分析。接下来,我们通过分子对接研究评估了Calebin-A与涉及非酒精性脂肪肝的重要枢纽蛋白之间可能存在的相互作用。结果我们发现了87个与非酒精性脂肪肝相关的Calebin-A靶标交叉基因。PPI网络分析引入了10个枢纽基因(TP53、TNF、STAT3、HSP90AA1、PTGS2、HDAC6、ABCB1、CCT2、NR1I2和GUSB)。在 KEGG 富集中,大部分与鞘磷脂、血管内皮生长因子 A(VEGFA)、C 型凝集素受体和丝裂原活化蛋白激酶(MAPK)信号通路有关。87 个交叉基因所描述的生物过程主要涉及调节细胞凋亡过程、细胞因子产生和细胞内信号转导。分子对接结果还表明,Calebin-A 与与非酒精性脂肪肝相关的枢纽蛋白有很高的结合亲和力。结论我们在这里发现,Calebin-A 通过影响几个关键基因/蛋白和通路,可能会抑制非酒精性脂肪肝的进展。
{"title":"Effect of Calebin-A on Critical Genes Related to NAFLD: A Protein-Protein Interaction Network and Molecular Docking Study","authors":"Ali Mahmoudi, Mohammad Mahdi Hajihasani, Muhammed Majeed, Tannaz Jamialahmadi, Amirhossein Sahebkar","doi":"10.2174/0113892029280454240214072212","DOIUrl":"https://doi.org/10.2174/0113892029280454240214072212","url":null,"abstract":"Background:: Calebin-A is a minor phytoconstituent of turmeric known for its activity against inflammation, oxidative stress, cancerous, and metabolic disorders like Non-alcoholic fatty liver disease(NAFLD). Based on bioinformatic tools, the present study explored the intersection of possible targets that interacted with Calebin-A and the essential genes involved in NAFLD. Subsequently, the details of the interaction of critical proteins with Calebin-A were investigated using the molecular docking technique. Methods:: We first probed the intersection of genes/ proteins between NAFLD and Calebin-A through online databases. Besides, we performed an enrichment analysis using the ClueGO plugin to investigate signaling pathways and gene ontology. Next, we evaluate the possible interaction of Calebin-A with significant hub proteins involved in NAFLD through a molecular docking study. Results:: We identified 87 intersection genes Calebin-A targets associated with NAFLD. PPI network analysis introduced 10 hub genes (TP53, TNF, STAT3, HSP90AA1, PTGS2, HDAC6, ABCB1, CCT2, NR1I2, and GUSB). In KEGG enrichment, most were associated with Sphingolipid, vascular endothelial growth factor A (VEGFA), C-type lectin receptor, and mitogen-activated protein kinase (MAPK) signaling pathways. The biological processes described in 87 intersection genes are mostly concerned with regulating the apoptotic process, cytokine production, and intracellular signal transduction. Molecular docking results also directed that Calebin-A had a high affinity to bind hub proteins linked to NAFLD. Conclusion:: Here, we showed that Calebin-A, through its effect on several critical genes/ proteins and pathways, might repress the progression of NAFLD.","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"11 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140004337","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Preface 25 Years of Current Genomics. 前言 当前基因组学 25 年。
IF 1.8 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-23 DOI: 10.2174/138920292501240205235837
Fabio Coppedè
{"title":"Preface 25 Years of Current Genomics.","authors":"Fabio Coppedè","doi":"10.2174/138920292501240205235837","DOIUrl":"10.2174/138920292501240205235837","url":null,"abstract":"","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"25 1","pages":"1"},"PeriodicalIF":1.8,"publicationDate":"2024-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10964086/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140305146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
DHFS-ECM: Design of a Dual Heuristic Feature Selection-based Ensemble Classification Model for the Identification of Bamboo Species from Genomic Sequences DHFS-ECM:设计基于双重启发式特征选择的集合分类模型,从基因组序列中识别竹子物种
IF 2.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-21 DOI: 10.2174/0113892029268176240125055419
Aditi R. Durge, Deepti D. Shrimankar
Problem: Analyzing genomic sequences plays a crucial role in understanding biological diversity and classifying Bamboo species. Existing methods for genomic sequence analysis suffer from limitations such as complexity, low accuracy, and the need for constant reconfiguration in response to evolving genomic datasets. Aim: This study addresses these limitations by introducing a novel Dual Heuristic Feature Selection- based Ensemble Classification Model (DHFS-ECM) for the precise identification of Bamboo species from genomic sequences. Methods: The proposed DHFS-ECM method employs a Genetic Algorithm to perform dual heuristic feature selection. This process maximizes inter-class variance, leading to the selection of informative N-gram feature sets. Subsequently, intra-class variance levels are used to create optimal training and validation sets, ensuring comprehensive coverage of class-specific features. The selected features are then processed through an ensemble classification layer, combining multiple stratification models for species-specific categorization. Results: Comparative analysis with state-of-the-art methods demonstrate that DHFS-ECM achieves remarkable improvements in accuracy (9.5%), precision (5.9%), recall (8.5%), and AUC performance (4.5%). Importantly, the model maintains its performance even with an increased number of species classes due to the continuous learning facilitated by the Dual Heuristic Genetic Algorithm Model. Conclusion: DHFS-ECM offers several key advantages, including efficient feature extraction, reduced model complexity, enhanced interpretability, and increased robustness and accuracy through the ensemble classification layer. These attributes make DHFS-ECM a promising tool for real-time clinical applications and a valuable contribution to the field of genomic sequence analysis.
问题:分析基因组序列对了解生物多样性和竹类分类起着至关重要的作用。现有的基因组序列分析方法存在一些局限性,如复杂性、准确性低以及需要根据不断变化的基因组数据集进行不断的重新配置。目的:针对这些局限性,本研究引入了一种新颖的基于双启发式特征选择的集合分类模型(DHFS-ECM),用于从基因组序列中精确识别竹类物种。方法:所提出的 DHFS-ECM 方法采用遗传算法进行双重启发式特征选择。这一过程可最大限度地提高类间方差,从而选择出信息丰富的 N-gram 特征集。随后,利用类内方差水平创建最佳训练集和验证集,确保全面覆盖特定类别的特征。然后通过集合分类层处理所选特征,结合多个分层模型进行物种分类。结果与最先进方法的对比分析表明,DHFS-ECM 在准确率(9.5%)、精确率(5.9%)、召回率(8.5%)和 AUC 性能(4.5%)方面都有显著提高。重要的是,由于双启发式遗传算法模型的持续学习功能,即使物种类别数量增加,该模型也能保持良好的性能。结论DHFS-ECM 具有几个关键优势,包括高效特征提取、降低模型复杂性、增强可解释性以及通过集合分类层提高稳健性和准确性。这些特点使 DHFS-ECM 成为一种很有前途的实时临床应用工具,也是对基因组序列分析领域的宝贵贡献。
{"title":"DHFS-ECM: Design of a Dual Heuristic Feature Selection-based Ensemble Classification Model for the Identification of Bamboo Species from Genomic Sequences","authors":"Aditi R. Durge, Deepti D. Shrimankar","doi":"10.2174/0113892029268176240125055419","DOIUrl":"https://doi.org/10.2174/0113892029268176240125055419","url":null,"abstract":"Problem: Analyzing genomic sequences plays a crucial role in understanding biological diversity and classifying Bamboo species. Existing methods for genomic sequence analysis suffer from limitations such as complexity, low accuracy, and the need for constant reconfiguration in response to evolving genomic datasets. Aim: This study addresses these limitations by introducing a novel Dual Heuristic Feature Selection- based Ensemble Classification Model (DHFS-ECM) for the precise identification of Bamboo species from genomic sequences. Methods: The proposed DHFS-ECM method employs a Genetic Algorithm to perform dual heuristic feature selection. This process maximizes inter-class variance, leading to the selection of informative N-gram feature sets. Subsequently, intra-class variance levels are used to create optimal training and validation sets, ensuring comprehensive coverage of class-specific features. The selected features are then processed through an ensemble classification layer, combining multiple stratification models for species-specific categorization. Results: Comparative analysis with state-of-the-art methods demonstrate that DHFS-ECM achieves remarkable improvements in accuracy (9.5%), precision (5.9%), recall (8.5%), and AUC performance (4.5%). Importantly, the model maintains its performance even with an increased number of species classes due to the continuous learning facilitated by the Dual Heuristic Genetic Algorithm Model. Conclusion: DHFS-ECM offers several key advantages, including efficient feature extraction, reduced model complexity, enhanced interpretability, and increased robustness and accuracy through the ensemble classification layer. These attributes make DHFS-ECM a promising tool for real-time clinical applications and a valuable contribution to the field of genomic sequence analysis.","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"134 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139951511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression Profiling of EMT Transcriptional Regulators ZEB1 and ZEB2 in Different Histopathological Grades of Oral Squamous Cell Carcinoma Patients 不同组织病理学分级口腔鳞状细胞癌患者 EMT 转录调控因子 ZEB1 和 ZEB2 的表达谱分析
IF 2.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-16 DOI: 10.2174/0113892029284920240212091903
Neha Baqai, Rafat Amin, Tehseen Fatima, Zeba Ahmed, Nousheen Faiz
Background: Pakistan has a high burden of oral cancers, with a prevalence rate of around 9%. Oral Squamous Cell Carcinoma (OSCC) accounts for about 90% of oral cancer cases. Epithelial to Mesenchymal Transition (EMT) gets highly stimulated in tumor cells by adopting subsequent malignant features of highly invasive cancer populations. Zinc Finger E-Box binding factors, ZEB1 and ZEB2, are regulatory proteins that promote EMT by suppressing the adherent ability of cells transforming into highly motile cancerous cells. The present study aimed to analyze the expression of EMT regulators, ZEB1 and ZEB2, and their association with the clinicopathological features in different grades of OSCC patients. Methods: Tissue samples were collected for both case and control groups from the recruited study participants. Cancer tissues (cases) were collected from the confirmed OSCC patients, and healthy tissues (controls) were collected from third-molar dental extraction patients. The study participants were recruited with informed consent and brief demographic and clinical characteristics. The case group was further segregated with respect to the histological cancer grading system into well-differentiated (WD), moderately differentiated (MD), and poorly differentiated (PD) squamous cell carcinoma (SCC) groups. RNA was extracted from the tissue samples for expression profiling of ZEB1 and ZEB2 genes through quantitative real-time PCR (qRT-PCR) Results: All of the recruited participants had a mean age of 46.55 ± 11.7 (years), with most of them belonging to Urdu speaking ethnic group and were married. The BMI (kg/m2 ) of the healthy participants was in the normal range (18-22 kg/m2 ). However, BMI was found to be reduced with the proliferation in the pathological state of cancer. The oral hygiene of patients was better than the healthy participants, possibly due to the strict oral hygiene practice concerns of consultants. Every recruited OSCC patient had one or multiple addiction habits for more than a year. Patients reported health frailty (46.6%), unhealed mouth sores (40%), swallowing difficulties and white/reddish marks (80%), and restricted mouth opening (64.4%). Furthermore, 82.2% of the recruited patients observed symptoms within 1-12 months, and buccal mucosa was the most exposed tumor site among 55.6% of the patients. Expression profiling of EMT regulators showed gradual over-expressions of ZEB1 (8, 20, and 42 folds) and ZEB2 (4, 10, and 18 folds) in respective histological cancer grades. Conclusion: High expressions of ZEBs have been significantly associated with cancer progression and poor health. However, no association was found between OSCC with other clinicopathological features when compared to healthy controls
背景:巴基斯坦的口腔癌发病率约为 9%,负担沉重。口腔鳞状细胞癌(OSCC)约占口腔癌病例的 90%。上皮细胞向间质转化(EMT)在肿瘤细胞中受到高度刺激,使其具有高侵袭性癌症群体的恶性特征。锌指E-Box结合因子ZEB1和ZEB2是一种调控蛋白,可通过抑制细胞的粘附能力促进EMT转化为高度运动的癌细胞。本研究旨在分析不同等级 OSCC 患者中 EMT 调节因子 ZEB1 和 ZEB2 的表达及其与临床病理特征的关系。研究方法从招募的研究参与者中收集病例组和对照组的组织样本。癌症组织(病例)取自确诊的 OSCC 患者,健康组织(对照)取自第三磨牙拔牙患者。研究人员在征得知情同意和简要的人口统计学和临床特征后被招募。病例组根据癌症组织学分级系统进一步分为分化良好(WD)、中度分化(MD)和分化不良(PD)鳞状细胞癌(SCC)组。从组织样本中提取 RNA,通过定量实时 PCR(qRT-PCR)分析 ZEB1 和 ZEB2 基因的表达情况:所有受试者的平均年龄为(46.55±11.7)岁,大多数人属于乌尔都语族群,已婚。健康参与者的体重指数(千克/平方米)在正常范围内(18-22 千克/平方米)。然而,在癌症的病理状态下,体重指数会随着癌细胞的增殖而降低。患者的口腔卫生比健康参与者好,这可能是由于顾问对口腔卫生的严格要求。每位被招募的 OSCC 患者都有一种或多种成瘾习惯,时间超过一年。患者表示身体虚弱(46.6%)、口腔溃疡未愈合(40%)、吞咽困难和白痕/红痕(80%)以及张口受限(64.4%)。此外,82.2%的患者在1-12个月内出现症状,55.6%的患者口腔黏膜是肿瘤暴露最多的部位。EMT调控因子的表达谱分析显示,ZEB1(8、20和42倍)和ZEB2(4、10和18倍)在各组织学癌症分级中逐渐过度表达。结论ZEBs的高表达与癌症进展和健康状况不佳密切相关。然而,与健康对照组相比,未发现 OSCC 与其他临床病理特征之间存在关联。
{"title":"Expression Profiling of EMT Transcriptional Regulators ZEB1 and ZEB2 in Different Histopathological Grades of Oral Squamous Cell Carcinoma Patients","authors":"Neha Baqai, Rafat Amin, Tehseen Fatima, Zeba Ahmed, Nousheen Faiz","doi":"10.2174/0113892029284920240212091903","DOIUrl":"https://doi.org/10.2174/0113892029284920240212091903","url":null,"abstract":"Background: Pakistan has a high burden of oral cancers, with a prevalence rate of around 9%. Oral Squamous Cell Carcinoma (OSCC) accounts for about 90% of oral cancer cases. Epithelial to Mesenchymal Transition (EMT) gets highly stimulated in tumor cells by adopting subsequent malignant features of highly invasive cancer populations. Zinc Finger E-Box binding factors, ZEB1 and ZEB2, are regulatory proteins that promote EMT by suppressing the adherent ability of cells transforming into highly motile cancerous cells. The present study aimed to analyze the expression of EMT regulators, ZEB1 and ZEB2, and their association with the clinicopathological features in different grades of OSCC patients. Methods: Tissue samples were collected for both case and control groups from the recruited study participants. Cancer tissues (cases) were collected from the confirmed OSCC patients, and healthy tissues (controls) were collected from third-molar dental extraction patients. The study participants were recruited with informed consent and brief demographic and clinical characteristics. The case group was further segregated with respect to the histological cancer grading system into well-differentiated (WD), moderately differentiated (MD), and poorly differentiated (PD) squamous cell carcinoma (SCC) groups. RNA was extracted from the tissue samples for expression profiling of ZEB1 and ZEB2 genes through quantitative real-time PCR (qRT-PCR) Results: All of the recruited participants had a mean age of 46.55 ± 11.7 (years), with most of them belonging to Urdu speaking ethnic group and were married. The BMI (kg/m2 ) of the healthy participants was in the normal range (18-22 kg/m2 ). However, BMI was found to be reduced with the proliferation in the pathological state of cancer. The oral hygiene of patients was better than the healthy participants, possibly due to the strict oral hygiene practice concerns of consultants. Every recruited OSCC patient had one or multiple addiction habits for more than a year. Patients reported health frailty (46.6%), unhealed mouth sores (40%), swallowing difficulties and white/reddish marks (80%), and restricted mouth opening (64.4%). Furthermore, 82.2% of the recruited patients observed symptoms within 1-12 months, and buccal mucosa was the most exposed tumor site among 55.6% of the patients. Expression profiling of EMT regulators showed gradual over-expressions of ZEB1 (8, 20, and 42 folds) and ZEB2 (4, 10, and 18 folds) in respective histological cancer grades. Conclusion: High expressions of ZEBs have been significantly associated with cancer progression and poor health. However, no association was found between OSCC with other clinicopathological features when compared to healthy controls","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"87 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-02-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139751828","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2 COVID-19:关于 SARS-CoV-2 的基因组特征、发病机制、免疫生物标志物、治疗方案和临床更新的最新见解
IF 2.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-02-07 DOI: 10.2174/0113892029291098240129113500
Rohitas Deshmukh, Ranjit K Harwansh, Akash Garg, Sakshi Mishra, Rutvi Agrawal, Rajendra Jangde
: SARS-CoV-2 is a highly contagious and transmissible viral infection that first emerged in 2019 and since then has sparked an epidemic of severe respiratory problems identified as “coronavirus disease 2019” (COVID-19) that causes a hazard to human life and safety. The virus developed mainly from bats. The current epidemic has presented a significant warning to life across the world by showing mutation. There are different tests available for testing Coronavirus, and RTPCR is the best, giving more accurate results, but it is also time-consuming. There are different options available for treating n-CoV-19, which include medications such as Remdesivir, corticosteroids, plasma therapy, Dexamethasone therapy, etc. The development of vaccines such as BNT126b2, ChAdOX1, mRNA-1273 and BBIBP-CorV has provided great relief in dealing with the virus as they decreased the mortality rate. BNT126b2 and ChAdOX1 are two n-CoV vaccines found to be most effective in controlling the spread of infection. In the future, nanotechnology-based vaccines and immune engineering techniques can be helpful for further research on Coronavirus and treatment of this deadly virus. The existing knowledge about the existence of SARS-- CoV-2, along with its variants, is summarized in this review. This review, based on recently published findings, presents the core genetics of COVID-19, including heritable characteristics, pathogenesis, immunological biomarkers, treatment options and clinical updates on the virus, along with patents.
:SARS-CoV-2 是一种高度传染性和传播性的病毒感染,于 2019 年首次出现,此后引发了严重呼吸道问题的流行,被认定为 "冠状病毒病 2019"(COVID-19),对人类生命安全造成危害。该病毒主要由蝙蝠发展而来。目前的疫情出现变异,给全球生命带来了重大警示。目前有不同的检测方法来检测冠状病毒,其中 RTPCR 是最好的方法,它能提供更准确的结果,但也很耗时。治疗 n-CoV-19 有多种方案,包括雷米地韦等药物、皮质类固醇、血浆疗法、地塞米松疗法等。BNT126b2、ChAdOX1、mRNA-1273 和 BBIBP-CorV 等疫苗的开发大大降低了病毒的死亡率。BNT126b2 和 ChAdOX1 是在控制感染传播方面最有效的两种 n-CoV 疫苗。未来,基于纳米技术的疫苗和免疫工程技术将有助于进一步研究冠状病毒和治疗这种致命病毒。本综述概述了有关 SARS--CoV-2及其变种存在的现有知识。本综述以最近发表的研究结果为基础,介绍了 COVID-19 的核心遗传学,包括遗传特征、致病机理、免疫学生物标志物、治疗方案和该病毒的最新临床研究成果以及专利。
{"title":"COVID-19: Recent Insight in Genomic Feature, Pathogenesis, Immunological Biomarkers, Treatment Options and Clinical Updates on SARS-CoV-2","authors":"Rohitas Deshmukh, Ranjit K Harwansh, Akash Garg, Sakshi Mishra, Rutvi Agrawal, Rajendra Jangde","doi":"10.2174/0113892029291098240129113500","DOIUrl":"https://doi.org/10.2174/0113892029291098240129113500","url":null,"abstract":": SARS-CoV-2 is a highly contagious and transmissible viral infection that first emerged in 2019 and since then has sparked an epidemic of severe respiratory problems identified as “coronavirus disease 2019” (COVID-19) that causes a hazard to human life and safety. The virus developed mainly from bats. The current epidemic has presented a significant warning to life across the world by showing mutation. There are different tests available for testing Coronavirus, and RTPCR is the best, giving more accurate results, but it is also time-consuming. There are different options available for treating n-CoV-19, which include medications such as Remdesivir, corticosteroids, plasma therapy, Dexamethasone therapy, etc. The development of vaccines such as BNT126b2, ChAdOX1, mRNA-1273 and BBIBP-CorV has provided great relief in dealing with the virus as they decreased the mortality rate. BNT126b2 and ChAdOX1 are two n-CoV vaccines found to be most effective in controlling the spread of infection. In the future, nanotechnology-based vaccines and immune engineering techniques can be helpful for further research on Coronavirus and treatment of this deadly virus. The existing knowledge about the existence of SARS-- CoV-2, along with its variants, is summarized in this review. This review, based on recently published findings, presents the core genetics of COVID-19, including heritable characteristics, pathogenesis, immunological biomarkers, treatment options and clinical updates on the virus, along with patents.","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"49 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-02-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139751750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tertiary Lymphoid Structures Gene Signature Predicts Prognosis and Immune Infiltration Analysis in Head and Neck Squamous Cell Carcinoma 三级淋巴结构基因信号预测头颈部鳞状细胞癌的预后和免疫渗透分析
IF 2.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-01-29 DOI: 10.2174/0113892029278082240118053857
Aiyan Xing, Dongxiao Lv, Changshun Wu, Kai Zhou, Tianhui Zhao, Lihua Zhao, Huaqing Wang, Hong Feng
Objectives: This study aims to assess the prognostic implications of gene signature of the tertiary lymphoid structures (TLSs) in head and neck squamous cell carcinoma (HNSCC) and scrutinize the influence of TLS on immune infiltration. Methods: Patients with HNSCC from the Cancer Genome Atlas were categorized into high/low TLS signature groups based on the predetermined TLS signature threshold. The association of the TLS signature with the immune microenvironment, driver gene mutation status, and tumor mutational load was systematically analyzed. Validation was conducted using independent datasets (GSE41613 and GSE102349). Results: Patients with a high TLS signature score exhibited better prognosis compared to those with a low TLS signature score. The group with a high TLS signature score had significantly higher immune cell subpopulations compared to the group with a low TLS signature score. Moreover, the major immune cell subpopulations and immune circulation characteristics in the tumor immune microenvironment were positively correlated with the TLS signature. Mutational differences in driver genes were observed between the TLS signature high/low groups, primarily in the cell cycle and NRF2 signaling pathways. Patients with TP53 mutations and high TLS signature scores demonstrated a better prognosis compared to those with TP53 wild-type. In the independent cohort, the relationship between TLS signatures and patient prognosis and immune infiltration was also confirmed. Additionally, immune-related biological processes and signaling pathways were activated with elevated TLS signature. Conclusion: High TLS signature is a promising independent prognostic factor for HNSCC patients. Immunological analysis indicated a correlation between TLS and immune cell infiltration in HNSCC. These findings provide a theoretical basis for future applications of TLS signature in HNSCC prognosis and immunotherapy.
研究目的本研究旨在评估三级淋巴结构(TLS)基因特征对头颈部鳞状细胞癌(HNSCC)预后的影响,并仔细研究三级淋巴结构对免疫浸润的影响。研究方法根据预定的TLS特征阈值,将癌症基因组图谱中的HNSCC患者分为高/低TLS特征组。系统分析了TLS特征与免疫微环境、驱动基因突变状态和肿瘤突变负荷的关联。利用独立数据集(GSE41613 和 GSE102349)进行了验证。结果与TLS特征得分低的患者相比,TLS特征得分高的患者预后更好。与低TLS特征得分组相比,高TLS特征得分组的免疫细胞亚群明显较高。此外,肿瘤免疫微环境中的主要免疫细胞亚群和免疫循环特征与TLS特征呈正相关。在TLS特征高/低组之间观察到了驱动基因的突变差异,主要是在细胞周期和NRF2信号通路中。与TP53野生型患者相比,TP53突变且TLS特征得分高的患者预后更好。在独立队列中,TLS特征与患者预后和免疫浸润之间的关系也得到了证实。此外,免疫相关的生物过程和信号通路随着 TLS 特征的升高而被激活。结论高TLS特征是HNSCC患者一个有希望的独立预后因素。免疫学分析表明,TLS 与 HNSCC 中的免疫细胞浸润存在相关性。这些发现为未来将 TLS 特征应用于 HNSCC 预后和免疫疗法提供了理论依据。
{"title":"Tertiary Lymphoid Structures Gene Signature Predicts Prognosis and Immune Infiltration Analysis in Head and Neck Squamous Cell Carcinoma","authors":"Aiyan Xing, Dongxiao Lv, Changshun Wu, Kai Zhou, Tianhui Zhao, Lihua Zhao, Huaqing Wang, Hong Feng","doi":"10.2174/0113892029278082240118053857","DOIUrl":"https://doi.org/10.2174/0113892029278082240118053857","url":null,"abstract":"Objectives: This study aims to assess the prognostic implications of gene signature of the tertiary lymphoid structures (TLSs) in head and neck squamous cell carcinoma (HNSCC) and scrutinize the influence of TLS on immune infiltration. Methods: Patients with HNSCC from the Cancer Genome Atlas were categorized into high/low TLS signature groups based on the predetermined TLS signature threshold. The association of the TLS signature with the immune microenvironment, driver gene mutation status, and tumor mutational load was systematically analyzed. Validation was conducted using independent datasets (GSE41613 and GSE102349). Results: Patients with a high TLS signature score exhibited better prognosis compared to those with a low TLS signature score. The group with a high TLS signature score had significantly higher immune cell subpopulations compared to the group with a low TLS signature score. Moreover, the major immune cell subpopulations and immune circulation characteristics in the tumor immune microenvironment were positively correlated with the TLS signature. Mutational differences in driver genes were observed between the TLS signature high/low groups, primarily in the cell cycle and NRF2 signaling pathways. Patients with TP53 mutations and high TLS signature scores demonstrated a better prognosis compared to those with TP53 wild-type. In the independent cohort, the relationship between TLS signatures and patient prognosis and immune infiltration was also confirmed. Additionally, immune-related biological processes and signaling pathways were activated with elevated TLS signature. Conclusion: High TLS signature is a promising independent prognostic factor for HNSCC patients. Immunological analysis indicated a correlation between TLS and immune cell infiltration in HNSCC. These findings provide a theoretical basis for future applications of TLS signature in HNSCC prognosis and immunotherapy.","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"50 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139584907","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Methylation-Based Model for Prognostic Prediction in Lung Adenocarcinoma 基于甲基化的新型肺腺癌预后预测模型
IF 2.6 4区 生物学 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2024-01-23 DOI: 10.2174/0113892029277397231228062412
Manyuan Li, Xufeng Deng, Dong Zhou, Xiaoqing Liu, Jigang Dai, Quanxing Liu
Objective:: Specific methylation sites have shown promise in the early diagnosis of lung adenocarcinoma (LUAD). However, their utility in predicting LUAD prognosis remains unclear. This study aimed to construct a reliable methylation-based predictor for accurately predicting the prognosis of LUAD patients. Method:: DNA methylation data and survival data from LUAD patients were obtained from the TCGA and a GEO series. A DNA methylation-based signature was developed using univariate least absolute shrinkage and selection operators and multivariate Cox regression models. Result:: Eight CpG sites were identified and validated as optimal prognostic signatures for the overall survival of LUAD patients. Receiver operating characteristic analysis demonstrated the high predictive ability of the eight-site methylation signature combined with clinical factors for overall survival. Conclusion:: This research successfully identified a novel eight-site methylation signature for predicting the overall survival of LUAD patients through bioinformatic integrated analysis of gene methylation markers used in the early diagnosis of lung cancer.
目的::特定的甲基化位点有望用于肺腺癌(LUAD)的早期诊断。然而,它们在预测肺腺癌预后方面的作用仍不明确。本研究旨在构建一种可靠的基于甲基化的预测因子,以准确预测 LUAD 患者的预后。方法:从 TCGA 和 GEO 系列中获取 LUAD 患者的 DNA 甲基化数据和生存数据。使用单变量最小绝对缩减和选择算子以及多变量考克斯回归模型建立了基于DNA甲基化的特征。结果::鉴定并验证了八个 CpG 位点是 LUAD 患者总生存期的最佳预后特征。接收者操作特征分析表明,八个位点甲基化特征与临床因素相结合,对总生存期具有很高的预测能力。结论本研究通过对肺癌早期诊断中使用的基因甲基化标记进行生物信息学综合分析,成功鉴定出一种新型的八个位点甲基化特征,用于预测 LUAD 患者的总生存率。
{"title":"A Novel Methylation-Based Model for Prognostic Prediction in Lung Adenocarcinoma","authors":"Manyuan Li, Xufeng Deng, Dong Zhou, Xiaoqing Liu, Jigang Dai, Quanxing Liu","doi":"10.2174/0113892029277397231228062412","DOIUrl":"https://doi.org/10.2174/0113892029277397231228062412","url":null,"abstract":"Objective:: Specific methylation sites have shown promise in the early diagnosis of lung adenocarcinoma (LUAD). However, their utility in predicting LUAD prognosis remains unclear. This study aimed to construct a reliable methylation-based predictor for accurately predicting the prognosis of LUAD patients. Method:: DNA methylation data and survival data from LUAD patients were obtained from the TCGA and a GEO series. A DNA methylation-based signature was developed using univariate least absolute shrinkage and selection operators and multivariate Cox regression models. Result:: Eight CpG sites were identified and validated as optimal prognostic signatures for the overall survival of LUAD patients. Receiver operating characteristic analysis demonstrated the high predictive ability of the eight-site methylation signature combined with clinical factors for overall survival. Conclusion:: This research successfully identified a novel eight-site methylation signature for predicting the overall survival of LUAD patients through bioinformatic integrated analysis of gene methylation markers used in the early diagnosis of lung cancer.","PeriodicalId":10803,"journal":{"name":"Current Genomics","volume":"60 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2024-01-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139557725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Genomics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1